| Discipline name | Position | Best Scientists | Publications | D-Index |
|---|---|---|---|---|
| Chemistry | 596 | 25 | 28 | 13 |
The aim of Journal of Drug Targeting is to expand the discussion of research in Pharmacology, Drug delivery, In vivo, Biochemistry and Liposome. The work tackled in it goes beyond the discipline of Pharmacology as it also encompasses Doxorubicin. Drug delivery studies covered in Journal of Drug Targeting falls within the purview of Nanotechnology.
Issues in In vivo were discussed, taking into consideration concepts from other disciplines like Cancer research and In vitro. The journal holds forums on In vitro that merges themes from other disciplines such as Molecular biology and Cell culture. The Biochemistry study featured in Journal of Drug Targeting draws parallels with the field of Biophysics.
Journal of Drug Targeting dives deep in exploring the relationship between the study of Liposome and Vesicle. The studies in Drug carrier featured incorporate elements of Chromatography and Dosage form. Journal of Drug Targeting explores research in Pharmacokinetics and the adjacent study of Biodistribution.
The journal papers facilitate discussions on Drug carrier, Pharmacology, Drug delivery, In vivo and Biochemistry. The studies on Pharmacology discussed at the published articles can also contribute to research in the domains of Liposome and Doxorubicin. The most cited papers address concerns in Biochemistry which are intertwined with other disciplines, such as Molecular biology and Biophysics.
The main research concerns discussed in the journal are Cancer research, Drug delivery, Cell biology, Targeted drug delivery and Pharmacology. The journal explores topics in Cancer research which can be helpful for research in disciplines like Cancer cell, Cancer, Targeted therapy, Apoptosis and microRNA. In addition to Drug delivery research, it aims to explore topics under Nanoparticle, Computational biology and Drug.
Mesoporous silica and Biocompatibility are some topics wherein Nanoparticle research discussed in it have an impact. Some problems in Targeted drug delivery that were presented in Journal of Drug Targeting overlapped with concepts under Microvesicles and Organelle. The research on Pharmacology discussed in it draws on the closely related field of Liposome.
A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.
The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.
The top authors publishing in Journal of Drug Targeting (based on the number of publications) are:
The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.
Only papers with recognized affiliations are considered
The top affiliations publishing in Journal of Drug Targeting (based on the number of publications) are:
The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.
The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.
The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.
During the most recent 2021 edition, 6.14% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 13.08% were posted by at least one author from the top 10 institutions publishing in the journal. Another 10.28% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 11.21% of all publications and 65.42% were from other institutions.
A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.
The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.
The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.
Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).
The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:
The chart below illustrates experience levels of first authors in cases of publications with multiple authors.
Mohaddeseh Sajjadi;Mahmoud Nasrollahzadeh;Babak Jaleh;Ghazaleh Jamalipour Soufi
(2021)Morteza Rabiei;Soheila Kashanian;Soheila Kashanian;Seyedeh Sabereh Samavati;Shahriar Jamasb
(2020)Zaynab Sadeghi-Ghadi;Pedram Ebrahimnejad;Fereshteh Talebpour Amiri;Ali Nokhodchi
(2021)Dan Zhu;Xiao-Hua Zhu;Shen-Zhen Ren;Ya-Dong Lu
(2021)Sadegh Dehghani;Sadegh Dehghani;Maryam Hosseini;Soheila Haghgoo;Vahid Changizi
(2020)Tohid Mortezazadeh;Elham Gholibegloo;Mehdi Khoobi;Nader Riyahi Alam
(2020)Niloufar Maghsoudnia;Reza Baradaran Eftekhari;Alireza Naderi Sohi;Parisa Norouzi
(2020)Ehsan Khabazian;Faezeh Vakhshiteh;Parisa Norouzi;Yousef Fatahi
(2021)Jafar Akbari;Majid Saeedi;Katayoun Morteza-Semnani;Seyyed Mohammad Hassan Hashemi
(2021)Studying Chemistry in the USA opens doors to diverse career paths, many of which can be enhanced or pursued through specialized online degrees. For instance, those interested in combining science with business may explore pharmaceutical sales roles, with useful insights into pharma sales rep salary and career advancement opportunities available.
Alternatively, healthcare professionals are in high demand. Chemistry graduates can consider becoming a pharmacist, a role that leverages deep knowledge of chemical compounds and their effects. Guidance on how to become a pharmacist can help clarify the necessary steps and qualifications.
Chemistry also intersects with medical coding and nursing pathways. For example, earning certification as a certified professional coder (CPC) or enrolling in accelerated nursing programs can expand career options quickly. Explore options such as the 12-month accelerated nursing programs online for non nurses to transition smoothly into nursing, even without a prior healthcare background.
These related degrees and certifications complement a Chemistry background well, offering pathways tailored to personal interests and industry demands.
